Business Context and Reporting Period
This Form 6-K filing by Check-Cap Ltd. (referred to as Mbody AI Ltd. in metadata) covers the period of October 2017, specifically dated October 24, 2017. The company is a foreign private issuer based in Israel, focused on medical technology, specifically X-ray based imaging capsules for colonic screening.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure rather than a financial statement.
Material Changes
There are no material financial changes reported versus a prior comparable period. The primary material event is the acceptance of a clinical abstract for presentation at a major medical conference.
Outlook, Commentary, and Risks
Management Commentary and Events: On October 24, 2017, the Company announced that an abstract titled "Clinical Performance of a Novel X-ray Based Imaging Capsule for Colonic Screening" was accepted for oral presentation. This presentation is scheduled for the late-breaking session at United European Gastroenterology (UEG) Week 2017 in Barcelona, Spain, from October 28 to November 1, 2017.
Risks and Contingencies: The filing does not explicitly detail new risks or contingencies beyond the standard nature of clinical data presentation.
Key Facts for Investor Verification
- Verify the date and location of the UEG Week 2017 presentation (Barcelona, Oct 28 - Nov 1, 2017).
- Confirm the specific clinical data or results presented in the abstract regarding the X-ray based imaging capsule.
- Review the attached press release (Exhibit 99.1) for detailed technical specifications or trial outcomes.
- Note that this filing incorporates information into multiple registration statements (S-8, F-3, and F-1).